What are the differential diagnoses and recommended work‑up for a 19‑year‑old male with near‑syncope at work and positional dizziness, normal orthostatic vitals, sinus rhythm with left‑ventricular hypertrophy (LVH) on ECG, and isolated elevation of AST (aspartate aminotransferase) and ALT (alanine aminotransferase)?

Differential Diagnoses and Work-Up for a 19-Year-Old Male with Near-Syncope, Positional Dizziness, and ECG Showing LVH

In a 19-year-old male presenting with near-syncope and LVH on ECG, hypertrophic cardiomyopathy (HCM) must be ruled out immediately with echocardiography, as this represents a potentially life-threatening cause of sudden cardiac death in young adults. 1

Key Differential Diagnoses

High-Priority Cardiac Causes (Must Rule Out First)

• Hypertrophic Cardiomyopathy (HCM): The presence of LVH on ECG in a young adult with syncope/near-syncope is highly concerning for HCM, which accounts for pediatric cardiac syncope due to obstruction to blood flow or primary arrhythmic etiology 1. HCM is defined by wall thickness ≥15 mm in one or more LV segments not explained by loading conditions 1.

• Inherited Arrhythmogenic Disorders: Long QT syndrome (LQTS), catecholaminergic polymorphic ventricular tachycardia (CPVT), Brugada syndrome, and arrhythmogenic right ventricular cardiomyopathy (ARVC) can all present with syncope in young adults 1.

• Cardiac Amyloidosis: Though less common in this age group, multiparametric CMR can detect cardiac amyloidosis in patients with undifferentiated concentric LVH, particularly when native T1 and ECV are elevated 2.

Moderate-Priority Causes

• Vasovagal Syncope (VVS): Neurally mediated syncope accounts for 75% of pediatric syncope and peaks between 15-19 years of age 1. Patients with VVS are more likely to be male and have lower resting heart rate (<70 bpm) 3.

• Postural Orthostatic Tachycardia Syndrome (POTS): Despite normal orthostatic vital signs in this case, POTS can present with near-syncope and positional dizziness in young adults, characterized by excessive heart rate increase on standing 3.

• Hepatic Causes of Elevated AST/ALT: The isolated transaminase elevation warrants consideration of primary liver disease, drug/supplement use (particularly anabolic steroids which can cause LVH), or cardiac hepatopathy from heart failure 1, 4.

Lower-Priority Considerations

• Orthostatic Hypotension: Already ruled out with normal orthostatic vital signs, though autonomic dysfunction can present with blood pressure fluctuations 5.

• Vestibular Disorders: Can mimic presyncope but typically present with vertigo rather than near-syncope 6.

Recommended Work-Up Algorithm

Immediate/Urgent Evaluation (Within Days)

1. Transthoracic Echocardiography 1:

   • Measure LV wall thickness in all segments (HCM diagnosis requires ≥15 mm in adults or ≥13 mm in first-degree relatives of HCM patients)
   • Assess for left ventricular outflow tract obstruction
   • Evaluate mitral valve apparatus abnormalities
   • Calculate left ventricular mass index (LVMI) to quantify LVH severity
   • Assess systolic and diastolic function

2. Detailed Family History 1:

   • Specifically inquire about premature sudden cardiac death in first- and second-degree relatives (age <40-50 years)
   • Ask about manner of death (during exertion, at rest, while sleeping)
   • Document family history of HCM, cardiomyopathy, or unexplained syncope

3. Exercise Stress Testing 1:

   • Assess for exercise-induced arrhythmias
   • Evaluate blood pressure response to exercise
   • Determine functional capacity

Secondary Evaluation (Within 1-2 Weeks)

1. Cardiac MRI with Gadolinium 1, 2:

   • If echocardiography shows LVH or is inconclusive
   • Assess for myocardial fibrosis (late gadolinium enhancement)
   • Measure native T1 mapping (>1122 ms suggests infiltrative disease) and ECV (>46% suggests amyloidosis)
   • Quantify non-vascular LGE segments (>10 segments suggests amyloidosis)

2. Hepatic Work-Up for Elevated AST/ALT 4:

   • Hepatitis panel (A, B, C)
   • Autoimmune markers (ANA, anti-smooth muscle antibody)
   • Iron studies, ceruloplasmin, alpha-1 antitrypsin
   • Right upper quadrant ultrasound
   • Detailed medication/supplement history (anabolic steroids, tacrolimus, hydroxychloroquine can cause LVH) 1
   • Calculate AST/ALT ratio and APRI score (elevated in cardiac hepatopathy from heart failure)

3. Extended Cardiac Monitoring 1:

   • 24-48 hour Holter monitor or event recorder
   • Consider implantable loop recorder if initial monitoring is negative but suspicion remains high

Specialized Testing (If Initial Work-Up Abnormal)

1. Genetic Testing 1:

   • Recommended if HCM is confirmed on imaging to enable cascade screening of relatives
   • Test for sarcomere protein gene mutations (MYH7, MYBPC3, TNNT2, TNNI3, TPM1)
   • Consider testing for infiltrative diseases if imaging suggests amyloidosis

2. Head-Up Tilt Table Testing 3:

   • If cardiac causes are excluded and symptoms persist
   • Measure plasma norepinephrine, epinephrine, renin, CT-proAVP, and MR-proANP at baseline and during tilt
   • Patients with VVS typically have resting HR <70 and MR-proANP >45 pmol/L (OR 3.99 for VVS diagnosis)

Critical Clinical Pitfalls

• Do not dismiss LVH in a young adult as "athletic heart" without comprehensive evaluation, as HCM can be fatal 1. Physiological hypertrophy from athletic training rarely exceeds 13-14 mm wall thickness.

• Normal orthostatic vital signs do not exclude POTS or autonomic dysfunction, as blood pressure fluctuations can be intermittent 5, 3.

• ECG criteria for LVH have limited specificity in young adults 7. The finding of LVH on ECG (using criteria such as R in aVL + S in V3 >35 mm in men or >25 mm in women) requires imaging confirmation.

• Elevated AST/ALT may indicate cardiac hepatopathy from unrecognized heart failure rather than primary liver disease 4. The AST/ALT ratio correlates with severity of left ventricular dysfunction.

• Syncope during exertion or while supine is particularly concerning for cardiac causes (HCM, arrhythmias) versus vasovagal syncope which typically occurs while standing 1.